Literature DB >> 12943667

Role of the adaptor protein CIKS in the activation of the IKK complex.

Claudio Mauro1, Pasquale Vito, Stefano Mellone, Francesco Pacifico, Alain Chariot, Silvestro Formisano, Antonio Leonardi.   

Abstract

Nuclear factor kappaB (NF-kappaB) plays a pivotal role in numerous cellular processes, including stress response, inflammation, and protection from apoptosis. Therefore, the activity of NF-kappaB needs to be tightly regulated. We have previously identified a novel gene, named CIKS (connection to IkappaB-kinase and SAPK), able to bind the regulatory sub-unit NEMO/IKKgamma and to activate NF-kappaB. Here, we demonstrate that CIKS forms homo-oligomers, interacts with NEMO/IKKgamma, and is recruited to the IKK-complex upon cell stimulation. In addition, we identified the regions of CIKS responsible for these functions. We found that the ability of CIKS to oligomerize, and to be recruited to the IKK-complex is not sufficient to activate the NF-kappaB. In fact, a deletion mutant of CIKS able to oligomerize, to interact with NEMO/IKKgamma, and to be recruited to the IKK-complex does not activate NF-kappaB, suggesting that CIKS needs a second level of regulation to efficiently activate NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943667     DOI: 10.1016/s0006-291x(03)01532-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.

Authors:  Caini Liu; Shadi Swaidani; Wen Qian; Zizhen Kang; Paige Sun; Yue Han; Chenhui Wang; Muhammet Fatih Gulen; Weiguo Yin; Chunjiang Zhang; Paul L Fox; Mark Aronica; Thomas A Hamilton; Saurav Misra; Junpeng Deng; Xiaoxia Li
Journal:  Sci Signal       Date:  2011-11-01       Impact factor: 8.192

2.  Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 Responses.

Authors:  Sylviane Lambert; William R Swindell; Lam C Tsoi; Stefan W Stoll; James T Elder
Journal:  J Invest Dermatol       Date:  2017-03-06       Impact factor: 8.551

3.  A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiency.

Authors:  Hong-Ying Wang; Vivek Gopalan; Ivona Aksentijevich; Meredith Yeager; Chi Adrian Ma; Yasmin Ali Mohamoud; Mariam Quinones; Casey Matthews; Joseph Boland; Julie E Niemela; Troy R Torgerson; Silvia Giliani; Gulbu Uzel; Jordan S Orange; Ralph Shapiro; Luigi Notarangelo; Hans D Ochs; Thomas Fleisher; Daniel Kastner; Stephen J Chanock; Ashish Jain
Journal:  Hum Mutat       Date:  2010-09       Impact factor: 4.878

Review 4.  Inhibitory kappa B Kinases as targets for pharmacological regulation.

Authors:  Carly Gamble; Kathryn McIntosh; Rebecca Scott; Ka Ho Ho; Robin Plevin; Andrew Paul
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms.

Authors:  Søren Ulrik Sønder; Sun Saret; Wanhu Tang; Dan E Sturdevant; Stephen F Porcella; Ulrich Siebenlist
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

6.  CIKS/DDX3X interaction controls the stability of the Zc3h12a mRNA induced by IL-17.

Authors:  Domenico Somma; Paola Mastrovito; Marianeve Grieco; Alfonso Lavorgna; Angelica Pignalosa; Luigi Formisano; Anna Maria Salzano; Andrea Scaloni; Francesco Pacifico; Ulrich Siebenlist; Antonio Leonardi
Journal:  J Immunol       Date:  2015-02-20       Impact factor: 5.422

7.  The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.

Authors:  Wei-Kuang Liu; Pei-Fen Yen; Chia-Yi Chien; Ming-Ji Fann; Jin-Yuan Su; Chen-Kung Chou
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

8.  Crystal structure of IL-17 receptor B SEFIR domain.

Authors:  Bing Zhang; Caini Liu; Wen Qian; Yue Han; Xiaoxia Li; Junpeng Deng
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

9.  A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1.

Authors:  Katerina Wolf; Gregory V Plano; Kenneth A Fields
Journal:  Cell Microbiol       Date:  2009-01-21       Impact factor: 3.715

10.  CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.

Authors:  Anthony J Valente; Robert A Clark; Jalahalli M Siddesha; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2012-04-26       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.